New on the scene of remote monitoring, Biotricity is tackling cardiovascular disease with a “real-time, high-precision remote monitoring technology.” Earlier this year, the company secured FDA 510k approval for Bioflux, a 3-channel electrocardiogram (ECG) monitoring system designed for use by physicians.
Triggered notifications about a (Read more...)